[email protected] +44 20 8123 2220 (UK) +1 732 587 5005 (US) Contact Us | FAQ |

Global Pharmaceutical and Biopharmaceutical Safety Testing Service Market Research Report 2024(Status and Outlook)

November 2024 | 142 pages | ID: GE6A0C844A2FEN
Bosson Research

US$ 3,200.00

E-mail Delivery (PDF)

Download PDF Leaflet

Accepted cards
Wire Transfer
Checkout Later
Need Help? Ask a Question
Report Overview:

Biosafety testing is a series of assays to evaluate the potential biological risks of new biological products, including viral testing, microbial testing, cell and molecular testing, and analytic testing. Health authorities such as the European Medicines Agency (EMA) and the US Food and Drug Administration (FDA) require all biopharmaceutical products and vaccines to undergo stringent testing to ensure the product is safe and free of contaminants.

The Global Pharmaceutical and Biopharmaceutical Safety Testing Service Market Size was estimated at USD 3689.74 million in 2023 and is projected to reach USD 7166.62 million by 2029, exhibiting a CAGR of 11.70% during the forecast period.

This report provides a deep insight into the global Pharmaceutical and Biopharmaceutical Safety Testing Service market covering all its essential aspects. This ranges from a macro overview of the market to micro details of the market size, competitive landscape, development trend, niche market, key market drivers and challenges, SWOT analysis, Porter’s five forces analysis, value chain analysis, etc.

The analysis helps the reader to shape the competition within the industries and strategies for the competitive environment to enhance the potential profit. Furthermore, it provides a simple framework for evaluating and accessing the position of the business organization. The report structure also focuses on the competitive landscape of the Global Pharmaceutical and Biopharmaceutical Safety Testing Service Market, this report introduces in detail the market share, market performance, product situation, operation situation, etc. of the main players, which helps the readers in the industry to identify the main competitors and deeply understand the competition pattern of the market.

In a word, this report is a must-read for industry players, investors, researchers, consultants, business strategists, and all those who have any kind of stake or are planning to foray into the Pharmaceutical and Biopharmaceutical Safety Testing Service market in any manner.

Global Pharmaceutical and Biopharmaceutical Safety Testing Service Market: Market Segmentation Analysis

The research report includes specific segments by region (country), manufacturers, Type, and Application. Market segmentation creates subsets of a market based on product type, end-user or application, Geographic, and other factors. By understanding the market segments, the decision-maker can leverage this targeting in the product, sales, and marketing strategies. Market segments can power your product development cycles by informing how you create product offerings for different segments.

Key Company

Merck

Charles River Laboratories

Sartorius

Eurofins Scientific

SGS

Q2 Solutions

Samsung Biologics

Texcell

WuXi Biologics

Wuhan Canvest Biotechnology

Centre Testing International (CTI)

Suzhou Liangchen Biotechnology

JADE Biomedical

Standard Testing Group

Sino Tech World Biologicals

CAS Testing Technical Services

NTEK

Sino Biological

Miracle Points

Suzhou Cefety Bioscience

Zhejiang Hengyu Biological

Market Segmentation (by Type)

Raw Materials

Viral Banks

Cell Banks

Others

Market Segmentation (by Application)

Pharmaceutical and Biotechnology Companies

CROs and CDMOs

Academic and Research Institutions

Geographic Segmentation
  • North America (USA, Canada, Mexico)
  • Europe (Germany, UK, France, Russia, Italy, Rest of Europe)
  • Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Rest of Asia-Pacific)
  • South America (Brazil, Argentina, Columbia, Rest of South America)
  • The Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria, South Africa, Rest of MEA)
Key Benefits of This Market Research:
  • Industry drivers, restraints, and opportunities covered in the study
  • Neutral perspective on the market performance
  • Recent industry trends and developments
  • Competitive landscape & strategies of key players
  • Potential & niche segments and regions exhibiting promising growth covered
  • Historical, current, and projected market size, in terms of value
  • In-depth analysis of the Pharmaceutical and Biopharmaceutical Safety Testing Service Market
  • Overview of the regional outlook of the Pharmaceutical and Biopharmaceutical Safety Testing Service Market:
Key Reasons to Buy this Report:
  • Access to date statistics compiled by our researchers. These provide you with historical and forecast data, which is analyzed to tell you why your market is set to change
  • This enables you to anticipate market changes to remain ahead of your competitors
  • You will be able to copy data from the Excel spreadsheet straight into your marketing plans, business presentations, or other strategic documents
  • The concise analysis, clear graph, and table format will enable you to pinpoint the information you require quickly
  • Provision of market value (USD Billion) data for each segment and sub-segment
  • Indicates the region and segment that is expected to witness the fastest growth as well as to dominate the market
  • Analysis by geography highlighting the consumption of the product/service in the region as well as indicating the factors that are affecting the market within each region
  • Competitive landscape which incorporates the market ranking of the major players, along with new service/product launches, partnerships, business expansions, and acquisitions in the past five years of companies profiled
  • Extensive company profiles comprising of company overview, company insights, product benchmarking, and SWOT analysis for the major market players
  • The current as well as the future market outlook of the industry concerning recent developments which involve growth opportunities and drivers as well as challenges and restraints of both emerging as well as developed regions
  • Includes in-depth analysis of the market from various perspectives through Porter’s five forces analysis
  • Provides insight into the market through Value Chain
  • Market dynamics scenario, along with growth opportunities of the market in the years to come
  • 6-month post-sales analyst support
Customization of the Report

In case of any queries or customization requirements, please connect with our sales team, who will ensure that your requirements are met.

Note: this report may need to undergo a final check or review and this could take about 48 hours.

Chapter Outline

Chapter 1 mainly introduces the statistical scope of the report, market division standards, and market research methods.

Chapter 2 is an executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the Pharmaceutical and Biopharmaceutical Safety Testing Service Market and its likely evolution in the short to mid-term, and long term.

Chapter 3 makes a detailed analysis of the Market's Competitive Landscape of the market and provides the market share, capacity, output, price, latest development plan, merger, and acquisition information of the main manufacturers in the market.

Chapter 4 is the analysis of the whole market industrial chain, including the upstream and downstream of the industry, as well as Porter's five forces analysis.

Chapter 5 introduces the latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 6 provides the analysis of various market segments according to product types, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 7 provides the analysis of various market segments according to application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 8 provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.

Chapter 9 introduces the basic situation of the main companies in the market in detail, including product sales revenue, sales volume, price, gross profit margin, market share, product introduction, recent development, etc.

Chapter 10 provides a quantitative analysis of the market size and development potential of each region in the next five years.

Chapter 11 provides a quantitative analysis of the market size and development potential of each market segment (product type and application) in the next five years.

Chapter 12 is the main points and conclusions of the report.
1 RESEARCH METHODOLOGY AND STATISTICAL SCOPE

1.1 Market Definition and Statistical Scope of Pharmaceutical and Biopharmaceutical Safety Testing Service
1.2 Key Market Segments
  1.2.1 Pharmaceutical and Biopharmaceutical Safety Testing Service Segment by Type
  1.2.2 Pharmaceutical and Biopharmaceutical Safety Testing Service Segment by Application
1.3 Methodology & Sources of Information
  1.3.1 Research Methodology
  1.3.2 Research Process
  1.3.3 Market Breakdown and Data Triangulation
  1.3.4 Base Year
  1.3.5 Report Assumptions & Caveats

2 PHARMACEUTICAL AND BIOPHARMACEUTICAL SAFETY TESTING SERVICE MARKET OVERVIEW

2.1 Global Market Overview
2.2 Market Segment Executive Summary
2.3 Global Market Size by Region

3 PHARMACEUTICAL AND BIOPHARMACEUTICAL SAFETY TESTING SERVICE MARKET COMPETITIVE LANDSCAPE

3.1 Global Pharmaceutical and Biopharmaceutical Safety Testing Service Revenue Market Share by Company (2019-2024)
3.2 Pharmaceutical and Biopharmaceutical Safety Testing Service Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Company Pharmaceutical and Biopharmaceutical Safety Testing Service Market Size Sites, Area Served, Product Type
3.4 Pharmaceutical and Biopharmaceutical Safety Testing Service Market Competitive Situation and Trends
  3.4.1 Pharmaceutical and Biopharmaceutical Safety Testing Service Market Concentration Rate
  3.4.2 Global 5 and 10 Largest Pharmaceutical and Biopharmaceutical Safety Testing Service Players Market Share by Revenue
  3.4.3 Mergers & Acquisitions, Expansion

4 PHARMACEUTICAL AND BIOPHARMACEUTICAL SAFETY TESTING SERVICE VALUE CHAIN ANALYSIS

4.1 Pharmaceutical and Biopharmaceutical Safety Testing Service Value Chain Analysis
4.2 Midstream Market Analysis
4.3 Downstream Customer Analysis

5 THE DEVELOPMENT AND DYNAMICS OF PHARMACEUTICAL AND BIOPHARMACEUTICAL SAFETY TESTING SERVICE MARKET

5.1 Key Development Trends
5.2 Driving Factors
5.3 Market Challenges
5.4 Market Restraints
5.5 Industry News
  5.5.1 Mergers & Acquisitions
  5.5.2 Expansions
  5.5.3 Collaboration/Supply Contracts
5.6 Industry Policies

6 PHARMACEUTICAL AND BIOPHARMACEUTICAL SAFETY TESTING SERVICE MARKET SEGMENTATION BY TYPE

6.1 Evaluation Matrix of Segment Market Development Potential (Type)
6.2 Global Pharmaceutical and Biopharmaceutical Safety Testing Service Market Size Market Share by Type (2019-2024)
6.3 Global Pharmaceutical and Biopharmaceutical Safety Testing Service Market Size Growth Rate by Type (2019-2024)

7 PHARMACEUTICAL AND BIOPHARMACEUTICAL SAFETY TESTING SERVICE MARKET SEGMENTATION BY APPLICATION

7.1 Evaluation Matrix of Segment Market Development Potential (Application)
7.2 Global Pharmaceutical and Biopharmaceutical Safety Testing Service Market Size (M USD) by Application (2019-2024)
7.3 Global Pharmaceutical and Biopharmaceutical Safety Testing Service Market Size Growth Rate by Application (2019-2024)

8 PHARMACEUTICAL AND BIOPHARMACEUTICAL SAFETY TESTING SERVICE MARKET SEGMENTATION BY REGION

8.1 Global Pharmaceutical and Biopharmaceutical Safety Testing Service Market Size by Region
  8.1.1 Global Pharmaceutical and Biopharmaceutical Safety Testing Service Market Size by Region
  8.1.2 Global Pharmaceutical and Biopharmaceutical Safety Testing Service Market Size Market Share by Region
8.2 North America
  8.2.1 North America Pharmaceutical and Biopharmaceutical Safety Testing Service Market Size by Country
  8.2.2 U.S.
  8.2.3 Canada
  8.2.4 Mexico
8.3 Europe
  8.3.1 Europe Pharmaceutical and Biopharmaceutical Safety Testing Service Market Size by Country
  8.3.2 Germany
  8.3.3 France
  8.3.4 U.K.
  8.3.5 Italy
  8.3.6 Russia
8.4 Asia Pacific
  8.4.1 Asia Pacific Pharmaceutical and Biopharmaceutical Safety Testing Service Market Size by Region
  8.4.2 China
  8.4.3 Japan
  8.4.4 South Korea
  8.4.5 India
  8.4.6 Southeast Asia
8.5 South America
  8.5.1 South America Pharmaceutical and Biopharmaceutical Safety Testing Service Market Size by Country
  8.5.2 Brazil
  8.5.3 Argentina
  8.5.4 Columbia
8.6 Middle East and Africa
  8.6.1 Middle East and Africa Pharmaceutical and Biopharmaceutical Safety Testing Service Market Size by Region
  8.6.2 Saudi Arabia
  8.6.3 UAE
  8.6.4 Egypt
  8.6.5 Nigeria
  8.6.6 South Africa

9 KEY COMPANIES PROFILE

9.1 Merck
  9.1.1 Merck Pharmaceutical and Biopharmaceutical Safety Testing Service Basic Information
  9.1.2 Merck Pharmaceutical and Biopharmaceutical Safety Testing Service Product Overview
  9.1.3 Merck Pharmaceutical and Biopharmaceutical Safety Testing Service Product Market Performance
  9.1.4 Merck Pharmaceutical and Biopharmaceutical Safety Testing Service SWOT Analysis
  9.1.5 Merck Business Overview
  9.1.6 Merck Recent Developments
9.2 Charles River Laboratories
  9.2.1 Charles River Laboratories Pharmaceutical and Biopharmaceutical Safety Testing Service Basic Information
  9.2.2 Charles River Laboratories Pharmaceutical and Biopharmaceutical Safety Testing Service Product Overview
  9.2.3 Charles River Laboratories Pharmaceutical and Biopharmaceutical Safety Testing Service Product Market Performance
  9.2.4 Merck Pharmaceutical and Biopharmaceutical Safety Testing Service SWOT Analysis
  9.2.5 Charles River Laboratories Business Overview
  9.2.6 Charles River Laboratories Recent Developments
9.3 Sartorius
  9.3.1 Sartorius Pharmaceutical and Biopharmaceutical Safety Testing Service Basic Information
  9.3.2 Sartorius Pharmaceutical and Biopharmaceutical Safety Testing Service Product Overview
  9.3.3 Sartorius Pharmaceutical and Biopharmaceutical Safety Testing Service Product Market Performance
  9.3.4 Merck Pharmaceutical and Biopharmaceutical Safety Testing Service SWOT Analysis
  9.3.5 Sartorius Business Overview
  9.3.6 Sartorius Recent Developments
9.4 Eurofins Scientific
  9.4.1 Eurofins Scientific Pharmaceutical and Biopharmaceutical Safety Testing Service Basic Information
  9.4.2 Eurofins Scientific Pharmaceutical and Biopharmaceutical Safety Testing Service Product Overview
  9.4.3 Eurofins Scientific Pharmaceutical and Biopharmaceutical Safety Testing Service Product Market Performance
  9.4.4 Eurofins Scientific Business Overview
  9.4.5 Eurofins Scientific Recent Developments
9.5 SGS
  9.5.1 SGS Pharmaceutical and Biopharmaceutical Safety Testing Service Basic Information
  9.5.2 SGS Pharmaceutical and Biopharmaceutical Safety Testing Service Product Overview
  9.5.3 SGS Pharmaceutical and Biopharmaceutical Safety Testing Service Product Market Performance
  9.5.4 SGS Business Overview
  9.5.5 SGS Recent Developments
9.6 Q2 Solutions
  9.6.1 Q2 Solutions Pharmaceutical and Biopharmaceutical Safety Testing Service Basic Information
  9.6.2 Q2 Solutions Pharmaceutical and Biopharmaceutical Safety Testing Service Product Overview
  9.6.3 Q2 Solutions Pharmaceutical and Biopharmaceutical Safety Testing Service Product Market Performance
  9.6.4 Q2 Solutions Business Overview
  9.6.5 Q2 Solutions Recent Developments
9.7 Samsung Biologics
  9.7.1 Samsung Biologics Pharmaceutical and Biopharmaceutical Safety Testing Service Basic Information
  9.7.2 Samsung Biologics Pharmaceutical and Biopharmaceutical Safety Testing Service Product Overview
  9.7.3 Samsung Biologics Pharmaceutical and Biopharmaceutical Safety Testing Service Product Market Performance
  9.7.4 Samsung Biologics Business Overview
  9.7.5 Samsung Biologics Recent Developments
9.8 Texcell
  9.8.1 Texcell Pharmaceutical and Biopharmaceutical Safety Testing Service Basic Information
  9.8.2 Texcell Pharmaceutical and Biopharmaceutical Safety Testing Service Product Overview
  9.8.3 Texcell Pharmaceutical and Biopharmaceutical Safety Testing Service Product Market Performance
  9.8.4 Texcell Business Overview
  9.8.5 Texcell Recent Developments
9.9 WuXi Biologics
  9.9.1 WuXi Biologics Pharmaceutical and Biopharmaceutical Safety Testing Service Basic Information
  9.9.2 WuXi Biologics Pharmaceutical and Biopharmaceutical Safety Testing Service Product Overview
  9.9.3 WuXi Biologics Pharmaceutical and Biopharmaceutical Safety Testing Service Product Market Performance
  9.9.4 WuXi Biologics Business Overview
  9.9.5 WuXi Biologics Recent Developments
9.10 Wuhan Canvest Biotechnology
  9.10.1 Wuhan Canvest Biotechnology Pharmaceutical and Biopharmaceutical Safety Testing Service Basic Information
  9.10.2 Wuhan Canvest Biotechnology Pharmaceutical and Biopharmaceutical Safety Testing Service Product Overview
  9.10.3 Wuhan Canvest Biotechnology Pharmaceutical and Biopharmaceutical Safety Testing Service Product Market Performance
  9.10.4 Wuhan Canvest Biotechnology Business Overview
  9.10.5 Wuhan Canvest Biotechnology Recent Developments
9.11 Centre Testing International (CTI)
  9.11.1 Centre Testing International (CTI) Pharmaceutical and Biopharmaceutical Safety Testing Service Basic Information
  9.11.2 Centre Testing International (CTI) Pharmaceutical and Biopharmaceutical Safety Testing Service Product Overview
  9.11.3 Centre Testing International (CTI) Pharmaceutical and Biopharmaceutical Safety Testing Service Product Market Performance
  9.11.4 Centre Testing International (CTI) Business Overview
  9.11.5 Centre Testing International (CTI) Recent Developments
9.12 Suzhou Liangchen Biotechnology
  9.12.1 Suzhou Liangchen Biotechnology Pharmaceutical and Biopharmaceutical Safety Testing Service Basic Information
  9.12.2 Suzhou Liangchen Biotechnology Pharmaceutical and Biopharmaceutical Safety Testing Service Product Overview
  9.12.3 Suzhou Liangchen Biotechnology Pharmaceutical and Biopharmaceutical Safety Testing Service Product Market Performance
  9.12.4 Suzhou Liangchen Biotechnology Business Overview
  9.12.5 Suzhou Liangchen Biotechnology Recent Developments
9.13 JADE Biomedical
  9.13.1 JADE Biomedical Pharmaceutical and Biopharmaceutical Safety Testing Service Basic Information
  9.13.2 JADE Biomedical Pharmaceutical and Biopharmaceutical Safety Testing Service Product Overview
  9.13.3 JADE Biomedical Pharmaceutical and Biopharmaceutical Safety Testing Service Product Market Performance
  9.13.4 JADE Biomedical Business Overview
  9.13.5 JADE Biomedical Recent Developments
9.14 Standard Testing Group
  9.14.1 Standard Testing Group Pharmaceutical and Biopharmaceutical Safety Testing Service Basic Information
  9.14.2 Standard Testing Group Pharmaceutical and Biopharmaceutical Safety Testing Service Product Overview
  9.14.3 Standard Testing Group Pharmaceutical and Biopharmaceutical Safety Testing Service Product Market Performance
  9.14.4 Standard Testing Group Business Overview
  9.14.5 Standard Testing Group Recent Developments
9.15 Sino Tech World Biologicals
  9.15.1 Sino Tech World Biologicals Pharmaceutical and Biopharmaceutical Safety Testing Service Basic Information
  9.15.2 Sino Tech World Biologicals Pharmaceutical and Biopharmaceutical Safety Testing Service Product Overview
  9.15.3 Sino Tech World Biologicals Pharmaceutical and Biopharmaceutical Safety Testing Service Product Market Performance
  9.15.4 Sino Tech World Biologicals Business Overview
  9.15.5 Sino Tech World Biologicals Recent Developments
9.16 CAS Testing Technical Services
  9.16.1 CAS Testing Technical Services Pharmaceutical and Biopharmaceutical Safety Testing Service Basic Information
  9.16.2 CAS Testing Technical Services Pharmaceutical and Biopharmaceutical Safety Testing Service Product Overview
  9.16.3 CAS Testing Technical Services Pharmaceutical and Biopharmaceutical Safety Testing Service Product Market Performance
  9.16.4 CAS Testing Technical Services Business Overview
  9.16.5 CAS Testing Technical Services Recent Developments
9.17 NTEK
  9.17.1 NTEK Pharmaceutical and Biopharmaceutical Safety Testing Service Basic Information
  9.17.2 NTEK Pharmaceutical and Biopharmaceutical Safety Testing Service Product Overview
  9.17.3 NTEK Pharmaceutical and Biopharmaceutical Safety Testing Service Product Market Performance
  9.17.4 NTEK Business Overview
  9.17.5 NTEK Recent Developments
9.18 Sino Biological
  9.18.1 Sino Biological Pharmaceutical and Biopharmaceutical Safety Testing Service Basic Information
  9.18.2 Sino Biological Pharmaceutical and Biopharmaceutical Safety Testing Service Product Overview
  9.18.3 Sino Biological Pharmaceutical and Biopharmaceutical Safety Testing Service Product Market Performance
  9.18.4 Sino Biological Business Overview
  9.18.5 Sino Biological Recent Developments
9.19 Miracle Points
  9.19.1 Miracle Points Pharmaceutical and Biopharmaceutical Safety Testing Service Basic Information
  9.19.2 Miracle Points Pharmaceutical and Biopharmaceutical Safety Testing Service Product Overview
  9.19.3 Miracle Points Pharmaceutical and Biopharmaceutical Safety Testing Service Product Market Performance
  9.19.4 Miracle Points Business Overview
  9.19.5 Miracle Points Recent Developments
9.20 Suzhou Cefety Bioscience
  9.20.1 Suzhou Cefety Bioscience Pharmaceutical and Biopharmaceutical Safety Testing Service Basic Information
  9.20.2 Suzhou Cefety Bioscience Pharmaceutical and Biopharmaceutical Safety Testing Service Product Overview
  9.20.3 Suzhou Cefety Bioscience Pharmaceutical and Biopharmaceutical Safety Testing Service Product Market Performance
  9.20.4 Suzhou Cefety Bioscience Business Overview
  9.20.5 Suzhou Cefety Bioscience Recent Developments
9.21 Zhejiang Hengyu Biological
  9.21.1 Zhejiang Hengyu Biological Pharmaceutical and Biopharmaceutical Safety Testing Service Basic Information
  9.21.2 Zhejiang Hengyu Biological Pharmaceutical and Biopharmaceutical Safety Testing Service Product Overview
  9.21.3 Zhejiang Hengyu Biological Pharmaceutical and Biopharmaceutical Safety Testing Service Product Market Performance
  9.21.4 Zhejiang Hengyu Biological Business Overview
  9.21.5 Zhejiang Hengyu Biological Recent Developments

10 PHARMACEUTICAL AND BIOPHARMACEUTICAL SAFETY TESTING SERVICE REGIONAL MARKET FORECAST

10.1 Global Pharmaceutical and Biopharmaceutical Safety Testing Service Market Size Forecast
10.2 Global Pharmaceutical and Biopharmaceutical Safety Testing Service Market Forecast by Region
  10.2.1 North America Market Size Forecast by Country
  10.2.2 Europe Pharmaceutical and Biopharmaceutical Safety Testing Service Market Size Forecast by Country
  10.2.3 Asia Pacific Pharmaceutical and Biopharmaceutical Safety Testing Service Market Size Forecast by Region
  10.2.4 South America Pharmaceutical and Biopharmaceutical Safety Testing Service Market Size Forecast by Country
  10.2.5 Middle East and Africa Forecasted Consumption of Pharmaceutical and Biopharmaceutical Safety Testing Service by Country

11 FORECAST MARKET BY TYPE AND BY APPLICATION (2025-2030)

11.1 Global Pharmaceutical and Biopharmaceutical Safety Testing Service Market Forecast by Type (2025-2030)
11.2 Global Pharmaceutical and Biopharmaceutical Safety Testing Service Market Forecast by Application (2025-2030)

12 CONCLUSION AND KEY FINDINGS

LIST OF TABLES

Table 1. Introduction of the Type
Table 2. Introduction of the Application
Table 3. Market Size (M USD) Segment Executive Summary
Table 4. Pharmaceutical and Biopharmaceutical Safety Testing Service Market Size Comparison by Region (M USD)
Table 5. Global Pharmaceutical and Biopharmaceutical Safety Testing Service Revenue (M USD) by Company (2019-2024)
Table 6. Global Pharmaceutical and Biopharmaceutical Safety Testing Service Revenue Share by Company (2019-2024)
Table 7. Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Pharmaceutical and Biopharmaceutical Safety Testing Service as of 2022)
Table 8. Company Pharmaceutical and Biopharmaceutical Safety Testing Service Market Size Sites and Area Served
Table 9. Company Pharmaceutical and Biopharmaceutical Safety Testing Service Product Type
Table 10. Global Pharmaceutical and Biopharmaceutical Safety Testing Service Company Market Concentration Ratio (CR5 and HHI)
Table 11. Mergers & Acquisitions, Expansion Plans
Table 12. Value Chain Map of Pharmaceutical and Biopharmaceutical Safety Testing Service
Table 13. Midstream Market Analysis
Table 14. Downstream Customer Analysis
Table 15. Key Development Trends
Table 16. Driving Factors
Table 17. Pharmaceutical and Biopharmaceutical Safety Testing Service Market Challenges
Table 18. Global Pharmaceutical and Biopharmaceutical Safety Testing Service Market Size by Type (M USD)
Table 19. Global Pharmaceutical and Biopharmaceutical Safety Testing Service Market Size (M USD) by Type (2019-2024)
Table 20. Global Pharmaceutical and Biopharmaceutical Safety Testing Service Market Size Share by Type (2019-2024)
Table 21. Global Pharmaceutical and Biopharmaceutical Safety Testing Service Market Size Growth Rate by Type (2019-2024)
Table 22. Global Pharmaceutical and Biopharmaceutical Safety Testing Service Market Size by Application
Table 23. Global Pharmaceutical and Biopharmaceutical Safety Testing Service Market Size by Application (2019-2024) & (M USD)
Table 24. Global Pharmaceutical and Biopharmaceutical Safety Testing Service Market Share by Application (2019-2024)
Table 25. Global Pharmaceutical and Biopharmaceutical Safety Testing Service Market Size Growth Rate by Application (2019-2024)
Table 26. Global Pharmaceutical and Biopharmaceutical Safety Testing Service Market Size by Region (2019-2024) & (M USD)
Table 27. Global Pharmaceutical and Biopharmaceutical Safety Testing Service Market Size Market Share by Region (2019-2024)
Table 28. North America Pharmaceutical and Biopharmaceutical Safety Testing Service Market Size by Country (2019-2024) & (M USD)
Table 29. Europe Pharmaceutical and Biopharmaceutical Safety Testing Service Market Size by Country (2019-2024) & (M USD)
Table 30. Asia Pacific Pharmaceutical and Biopharmaceutical Safety Testing Service Market Size by Region (2019-2024) & (M USD)
Table 31. South America Pharmaceutical and Biopharmaceutical Safety Testing Service Market Size by Country (2019-2024) & (M USD)
Table 32. Middle East and Africa Pharmaceutical and Biopharmaceutical Safety Testing Service Market Size by Region (2019-2024) & (M USD)
Table 33. Merck Pharmaceutical and Biopharmaceutical Safety Testing Service Basic Information
Table 34. Merck Pharmaceutical and Biopharmaceutical Safety Testing Service Product Overview
Table 35. Merck Pharmaceutical and Biopharmaceutical Safety Testing Service Revenue (M USD) and Gross Margin (2019-2024)
Table 36. Merck Pharmaceutical and Biopharmaceutical Safety Testing Service SWOT Analysis
Table 37. Merck Business Overview
Table 38. Merck Recent Developments
Table 39. Charles River Laboratories Pharmaceutical and Biopharmaceutical Safety Testing Service Basic Information
Table 40. Charles River Laboratories Pharmaceutical and Biopharmaceutical Safety Testing Service Product Overview
Table 41. Charles River Laboratories Pharmaceutical and Biopharmaceutical Safety Testing Service Revenue (M USD) and Gross Margin (2019-2024)
Table 42. Merck Pharmaceutical and Biopharmaceutical Safety Testing Service SWOT Analysis
Table 43. Charles River Laboratories Business Overview
Table 44. Charles River Laboratories Recent Developments
Table 45. Sartorius Pharmaceutical and Biopharmaceutical Safety Testing Service Basic Information
Table 46. Sartorius Pharmaceutical and Biopharmaceutical Safety Testing Service Product Overview
Table 47. Sartorius Pharmaceutical and Biopharmaceutical Safety Testing Service Revenue (M USD) and Gross Margin (2019-2024)
Table 48. Merck Pharmaceutical and Biopharmaceutical Safety Testing Service SWOT Analysis
Table 49. Sartorius Business Overview
Table 50. Sartorius Recent Developments
Table 51. Eurofins Scientific Pharmaceutical and Biopharmaceutical Safety Testing Service Basic Information
Table 52. Eurofins Scientific Pharmaceutical and Biopharmaceutical Safety Testing Service Product Overview
Table 53. Eurofins Scientific Pharmaceutical and Biopharmaceutical Safety Testing Service Revenue (M USD) and Gross Margin (2019-2024)
Table 54. Eurofins Scientific Business Overview
Table 55. Eurofins Scientific Recent Developments
Table 56. SGS Pharmaceutical and Biopharmaceutical Safety Testing Service Basic Information
Table 57. SGS Pharmaceutical and Biopharmaceutical Safety Testing Service Product Overview
Table 58. SGS Pharmaceutical and Biopharmaceutical Safety Testing Service Revenue (M USD) and Gross Margin (2019-2024)
Table 59. SGS Business Overview
Table 60. SGS Recent Developments
Table 61. Q2 Solutions Pharmaceutical and Biopharmaceutical Safety Testing Service Basic Information
Table 62. Q2 Solutions Pharmaceutical and Biopharmaceutical Safety Testing Service Product Overview
Table 63. Q2 Solutions Pharmaceutical and Biopharmaceutical Safety Testing Service Revenue (M USD) and Gross Margin (2019-2024)
Table 64. Q2 Solutions Business Overview
Table 65. Q2 Solutions Recent Developments
Table 66. Samsung Biologics Pharmaceutical and Biopharmaceutical Safety Testing Service Basic Information
Table 67. Samsung Biologics Pharmaceutical and Biopharmaceutical Safety Testing Service Product Overview
Table 68. Samsung Biologics Pharmaceutical and Biopharmaceutical Safety Testing Service Revenue (M USD) and Gross Margin (2019-2024)
Table 69. Samsung Biologics Business Overview
Table 70. Samsung Biologics Recent Developments
Table 71. Texcell Pharmaceutical and Biopharmaceutical Safety Testing Service Basic Information
Table 72. Texcell Pharmaceutical and Biopharmaceutical Safety Testing Service Product Overview
Table 73. Texcell Pharmaceutical and Biopharmaceutical Safety Testing Service Revenue (M USD) and Gross Margin (2019-2024)
Table 74. Texcell Business Overview
Table 75. Texcell Recent Developments
Table 76. WuXi Biologics Pharmaceutical and Biopharmaceutical Safety Testing Service Basic Information
Table 77. WuXi Biologics Pharmaceutical and Biopharmaceutical Safety Testing Service Product Overview
Table 78. WuXi Biologics Pharmaceutical and Biopharmaceutical Safety Testing Service Revenue (M USD) and Gross Margin (2019-2024)
Table 79. WuXi Biologics Business Overview
Table 80. WuXi Biologics Recent Developments
Table 81. Wuhan Canvest Biotechnology Pharmaceutical and Biopharmaceutical Safety Testing Service Basic Information
Table 82. Wuhan Canvest Biotechnology Pharmaceutical and Biopharmaceutical Safety Testing Service Product Overview
Table 83. Wuhan Canvest Biotechnology Pharmaceutical and Biopharmaceutical Safety Testing Service Revenue (M USD) and Gross Margin (2019-2024)
Table 84. Wuhan Canvest Biotechnology Business Overview
Table 85. Wuhan Canvest Biotechnology Recent Developments
Table 86. Centre Testing International (CTI) Pharmaceutical and Biopharmaceutical Safety Testing Service Basic Information
Table 87. Centre Testing International (CTI) Pharmaceutical and Biopharmaceutical Safety Testing Service Product Overview
Table 88. Centre Testing International (CTI) Pharmaceutical and Biopharmaceutical Safety Testing Service Revenue (M USD) and Gross Margin (2019-2024)
Table 89. Centre Testing International (CTI) Business Overview
Table 90. Centre Testing International (CTI) Recent Developments
Table 91. Suzhou Liangchen Biotechnology Pharmaceutical and Biopharmaceutical Safety Testing Service Basic Information
Table 92. Suzhou Liangchen Biotechnology Pharmaceutical and Biopharmaceutical Safety Testing Service Product Overview
Table 93. Suzhou Liangchen Biotechnology Pharmaceutical and Biopharmaceutical Safety Testing Service Revenue (M USD) and Gross Margin (2019-2024)
Table 94. Suzhou Liangchen Biotechnology Business Overview
Table 95. Suzhou Liangchen Biotechnology Recent Developments
Table 96. JADE Biomedical Pharmaceutical and Biopharmaceutical Safety Testing Service Basic Information
Table 97. JADE Biomedical Pharmaceutical and Biopharmaceutical Safety Testing Service Product Overview
Table 98. JADE Biomedical Pharmaceutical and Biopharmaceutical Safety Testing Service Revenue (M USD) and Gross Margin (2019-2024)
Table 99. JADE Biomedical Business Overview
Table 100. JADE Biomedical Recent Developments
Table 101. Standard Testing Group Pharmaceutical and Biopharmaceutical Safety Testing Service Basic Information
Table 102. Standard Testing Group Pharmaceutical and Biopharmaceutical Safety Testing Service Product Overview
Table 103. Standard Testing Group Pharmaceutical and Biopharmaceutical Safety Testing Service Revenue (M USD) and Gross Margin (2019-2024)
Table 104. Standard Testing Group Business Overview
Table 105. Standard Testing Group Recent Developments
Table 106. Sino Tech World Biologicals Pharmaceutical and Biopharmaceutical Safety Testing Service Basic Information
Table 107. Sino Tech World Biologicals Pharmaceutical and Biopharmaceutical Safety Testing Service Product Overview
Table 108. Sino Tech World Biologicals Pharmaceutical and Biopharmaceutical Safety Testing Service Revenue (M USD) and Gross Margin (2019-2024)
Table 109. Sino Tech World Biologicals Business Overview
Table 110. Sino Tech World Biologicals Recent Developments
Table 111. CAS Testing Technical Services Pharmaceutical and Biopharmaceutical Safety Testing Service Basic Information
Table 112. CAS Testing Technical Services Pharmaceutical and Biopharmaceutical Safety Testing Service Product Overview
Table 113. CAS Testing Technical Services Pharmaceutical and Biopharmaceutical Safety Testing Service Revenue (M USD) and Gross Margin (2019-2024)
Table 114. CAS Testing Technical Services Business Overview
Table 115. CAS Testing Technical Services Recent Developments
Table 116. NTEK Pharmaceutical and Biopharmaceutical Safety Testing Service Basic Information
Table 117. NTEK Pharmaceutical and Biopharmaceutical Safety Testing Service Product Overview
Table 118. NTEK Pharmaceutical and Biopharmaceutical Safety Testing Service Revenue (M USD) and Gross Margin (2019-2024)
Table 119. NTEK Business Overview
Table 120. NTEK Recent Developments
Table 121. Sino Biological Pharmaceutical and Biopharmaceutical Safety Testing Service Basic Information
Table 122. Sino Biological Pharmaceutical and Biopharmaceutical Safety Testing Service Product Overview
Table 123. Sino Biological Pharmaceutical and Biopharmaceutical Safety Testing Service Revenue (M USD) and Gross Margin (2019-2024)
Table 124. Sino Biological Business Overview
Table 125. Sino Biological Recent Developments
Table 126. Miracle Points Pharmaceutical and Biopharmaceutical Safety Testing Service Basic Information
Table 127. Miracle Points Pharmaceutical and Biopharmaceutical Safety Testing Service Product Overview
Table 128. Miracle Points Pharmaceutical and Biopharmaceutical Safety Testing Service Revenue (M USD) and Gross Margin (2019-2024)
Table 129. Miracle Points Business Overview
Table 130. Miracle Points Recent Developments
Table 131. Suzhou Cefety Bioscience Pharmaceutical and Biopharmaceutical Safety Testing Service Basic Information
Table 132. Suzhou Cefety Bioscience Pharmaceutical and Biopharmaceutical Safety Testing Service Product Overview
Table 133. Suzhou Cefety Bioscience Pharmaceutical and Biopharmaceutical Safety Testing Service Revenue (M USD) and Gross Margin (2019-2024)
Table 134. Suzhou Cefety Bioscience Business Overview
Table 135. Suzhou Cefety Bioscience Recent Developments
Table 136. Zhejiang Hengyu Biological Pharmaceutical and Biopharmaceutical Safety Testing Service Basic Information
Table 137. Zhejiang Hengyu Biological Pharmaceutical and Biopharmaceutical Safety Testing Service Product Overview
Table 138. Zhejiang Hengyu Biological Pharmaceutical and Biopharmaceutical Safety Testing Service Revenue (M USD) and Gross Margin (2019-2024)
Table 139. Zhejiang Hengyu Biological Business Overview
Table 140. Zhejiang Hengyu Biological Recent Developments
Table 141. Global Pharmaceutical and Biopharmaceutical Safety Testing Service Market Size Forecast by Region (2025-2030) & (M USD)
Table 142. North America Pharmaceutical and Biopharmaceutical Safety Testing Service Market Size Forecast by Country (2025-2030) & (M USD)
Table 143. Europe Pharmaceutical and Biopharmaceutical Safety Testing Service Market Size Forecast by Country (2025-2030) & (M USD)
Table 144. Asia Pacific Pharmaceutical and Biopharmaceutical Safety Testing Service Market Size Forecast by Region (2025-2030) & (M USD)
Table 145. South America Pharmaceutical and Biopharmaceutical Safety Testing Service Market Size Forecast by Country (2025-2030) & (M USD)
Table 146. Middle East and Africa Pharmaceutical and Biopharmaceutical Safety Testing Service Market Size Forecast by Country (2025-2030) & (M USD)
Table 147. Global Pharmaceutical and Biopharmaceutical Safety Testing Service Market Size Forecast by Type (2025-2030) & (M USD)
Table 148. Global Pharmaceutical and Biopharmaceutical Safety Testing Service Market Size Forecast by Application (2025-2030) & (M USD)

LIST OF FIGURES

Figure 1. Industrial Chain of Pharmaceutical and Biopharmaceutical Safety Testing Service
Figure 2. Data Triangulation
Figure 3. Key Caveats
Figure 4. Global Pharmaceutical and Biopharmaceutical Safety Testing Service Market Size (M USD), 2019-2030
Figure 5. Global Pharmaceutical and Biopharmaceutical Safety Testing Service Market Size (M USD) (2019-2030)
Figure 6. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 7. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 8. Evaluation Matrix of Regional Market Development Potential
Figure 9. Pharmaceutical and Biopharmaceutical Safety Testing Service Market Size by Country (M USD)
Figure 10. Global Pharmaceutical and Biopharmaceutical Safety Testing Service Revenue Share by Company in 2023
Figure 11. Pharmaceutical and Biopharmaceutical Safety Testing Service Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2023
Figure 12. The Global 5 and 10 Largest Players: Market Share by Pharmaceutical and Biopharmaceutical Safety Testing Service Revenue in 2023
Figure 13. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 14. Global Pharmaceutical and Biopharmaceutical Safety Testing Service Market Share by Type
Figure 15. Market Size Share of Pharmaceutical and Biopharmaceutical Safety Testing Service by Type (2019-2024)
Figure 16. Market Size Market Share of Pharmaceutical and Biopharmaceutical Safety Testing Service by Type in 2022
Figure 17. Global Pharmaceutical and Biopharmaceutical Safety Testing Service Market Size Growth Rate by Type (2019-2024)
Figure 18. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 19. Global Pharmaceutical and Biopharmaceutical Safety Testing Service Market Share by Application
Figure 20. Global Pharmaceutical and Biopharmaceutical Safety Testing Service Market Share by Application (2019-2024)
Figure 21. Global Pharmaceutical and Biopharmaceutical Safety Testing Service Market Share by Application in 2022
Figure 22. Global Pharmaceutical and Biopharmaceutical Safety Testing Service Market Size Growth Rate by Application (2019-2024)
Figure 23. Global Pharmaceutical and Biopharmaceutical Safety Testing Service Market Size Market Share by Region (2019-2024)
Figure 24. North America Pharmaceutical and Biopharmaceutical Safety Testing Service Market Size and Growth Rate (2019-2024) & (M USD)
Figure 25. North America Pharmaceutical and Biopharmaceutical Safety Testing Service Market Size Market Share by Country in 2023
Figure 26. U.S. Pharmaceutical and Biopharmaceutical Safety Testing Service Market Size and Growth Rate (2019-2024) & (M USD)
Figure 27. Canada Pharmaceutical and Biopharmaceutical Safety Testing Service Market Size (M USD) and Growth Rate (2019-2024)
Figure 28. Mexico Pharmaceutical and Biopharmaceutical Safety Testing Service Market Size (Units) and Growth Rate (2019-2024)
Figure 29. Europe Pharmaceutical and Biopharmaceutical Safety Testing Service Market Size and Growth Rate (2019-2024) & (M USD)
Figure 30. Europe Pharmaceutical and Biopharmaceutical Safety Testing Service Market Size Market Share by Country in 2023
Figure 31. Germany Pharmaceutical and Biopharmaceutical Safety Testing Service Market Size and Growth Rate (2019-2024) & (M USD)
Figure 32. France Pharmaceutical and Biopharmaceutical Safety Testing Service Market Size and Growth Rate (2019-2024) & (M USD)
Figure 33. U.K. Pharmaceutical and Biopharmaceutical Safety Testing Service Market Size and Growth Rate (2019-2024) & (M USD)
Figure 34. Italy Pharmaceutical and Biopharmaceutical Safety Testing Service Market Size and Growth Rate (2019-2024) & (M USD)
Figure 35. Russia Pharmaceutical and Biopharmaceutical Safety Testing Service Market Size and Growth Rate (2019-2024) & (M USD)
Figure 36. Asia Pacific Pharmaceutical and Biopharmaceutical Safety Testing Service Market Size and Growth Rate (M USD)
Figure 37. Asia Pacific Pharmaceutical and Biopharmaceutical Safety Testing Service Market Size Market Share by Region in 2023
Figure 38. China Pharmaceutical and Biopharmaceutical Safety Testing Service Market Size and Growth Rate (2019-2024) & (M USD)
Figure 39. Japan Pharmaceutical and Biopharmaceutical Safety Testing Service Market Size and Growth Rate (2019-2024) & (M USD)
Figure 40. South Korea Pharmaceutical and Biopharmaceutical Safety Testing Service Market Size and Growth Rate (2019-2024) & (M USD)
Figure 41. India Pharmaceutical and Biopharmaceutical Safety Testing Service Market Size and Growth Rate (2019-2024) & (M USD)
Figure 42. Southeast Asia Pharmaceutical and Biopharmaceutical Safety Testing Service Market Size and Growth Rate (2019-2024) & (M USD)
Figure 43. South America Pharmaceutical and Biopharmaceutical Safety Testing Service Market Size and Growth Rate (M USD)
Figure 44. South America Pharmaceutical and Biopharmaceutical Safety Testing Service Market Size Market Share by Country in 2023
Figure 45. Brazil Pharmaceutical and Biopharmaceutical Safety Testing Service Market Size and Growth Rate (2019-2024) & (M USD)
Figure 46. Argentina Pharmaceutical and Biopharmaceutical Safety Testing Service Market Size and Growth Rate (2019-2024) & (M USD)
Figure 47. Columbia Pharmaceutical and Biopharmaceutical Safety Testing Service Market Size and Growth Rate (2019-2024) & (M USD)
Figure 48. Middle East and Africa Pharmaceutical and Biopharmaceutical Safety Testing Service Market Size and Growth Rate (M USD)
Figure 49. Middle East and Africa Pharmaceutical and Biopharmaceutical Safety Testing Service Market Size Market Share by Region in 2023
Figure 50. Saudi Arabia Pharmaceutical and Biopharmaceutical Safety Testing Service Market Size and Growth Rate (2019-2024) & (M USD)
Figure 51. UAE Pharmaceutical and Biopharmaceutical Safety Testing Service Market Size and Growth Rate (2019-2024) & (M USD)
Figure 52. Egypt Pharmaceutical and Biopharmaceutical Safety Testing Service Market Size and Growth Rate (2019-2024) & (M USD)
Figure 53. Nigeria Pharmaceutical and Biopharmaceutical Safety Testing Service Market Size and Growth Rate (2019-2024) & (M USD)
Figure 54. South Africa Pharmaceutical and Biopharmaceutical Safety Testing Service Market Size and Growth Rate (2019-2024) & (M USD)
Figure 55. Global Pharmaceutical and Biopharmaceutical Safety Testing Service Market Size Forecast by Value (2019-2030) & (M USD)
Figure 56. Global Pharmaceutical and Biopharmaceutical Safety Testing Service Market Share Forecast by Type (2025-2030)
Figure 57. Global Pharmaceutical and Biopharmaceutical Safety Testing Service Market Share Forecast by Application (2025-2030)


More Publications